Home > Report Information

Japan Microbiology Testing Market: Innovative Technologies and Emerging Business Opportunities

Venture Planning Group
December 13, 2012
976 Pages - SKU: VPG4943648

Abstract Table of Contents

Highlights

Comprehensive 976-page analysis of the Japanese microbiology testing market.
Major issues pertaining to the Japanese microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.
Ten-year test volume and sales forecasts for nearly 80 microbiology tests performed in Japanese hospitals, blood banks and commercial laboratories.
Instrumentation technologies and feature comparison of leading analyzers.
Sales and market shares of leading suppliers.
Emerging diagnostic technologies and their potential market applications.
Product development opportunities.
Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Business opportunities and strategic recommendations for suppliers.

Contains 976 pages and 160 tables

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.

A. Major Infectious Disease Tests: 1. AIDS; 2. Adenovirus; 3. Aeromonas; 4. Anthrax/Bacillus Anthracis; 5. Arboviruses; 6. Babesiosis; 7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea); 8. Blastocystis Hominis; 9. Brucella; 10. Campylobacter; 11. Candida; 12. Chagas Disease; 13. Chancroid; 14. Chlamydia; 15. Clostridium Difficile; 16. Coronaviruses; 17. Coxsackieviruses; 18. Creutzfeldt-Jakob’s Disease; 19. Cryptosporidium Parvum; 20. Cyclospora Cayetanensis; 21. Cytomegalovirus; 22. Ebola Virus; 23. E. Coli; 24. EchoVirus; 25. Encephalitis; 26. Enteroviruses; 27. Epstein-Barr Virus; 28. Giardia Lamblia; 29. Gonorrhea; 30. Granuloma Inguinale; 31. Hantavirus; 32. Helicobacter Pylori; 33. Hepatitis; 34. Herpes Simplex Virus; 35. Human Herpes Virus-6 (HHV-6); 36. Influenza Viruses; 37. Legionella; 38. Lyme Disease; 39. Lymphogranuloma Venereum (LGV); 40. Malaria; 41. Measles (Rubeola); 42. Meningitis; 43. Microsporidium; 44. Mononucleosis; 45. Mumps; 46. Mycoplasma; 47. Papillomaviruses; 48. Parvovirus B19; 49. Pneumonia; 50. Polyomaviruses; 51. Pseudomonas Aeruginosa; 52. Rabies; 53. Respiratory Syncytial Virus (RSV); 54. RhinoViruses; 55. RotaVirus (REOVIRUS); 56. Rubella(MEASLES); 57. Salmonellosis; 58. Septicemia; 59. Shigellosis; 60. Staphylococcus Aureus; 61. Streptococci; 62. Syphilis; 63. Toxoplasmosis; 64. Trichomonas Vaginalis; 65. Tuberculosis; 66. Vibrio; 67. West Nile Virus; 68. Yersina
B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies: 1. Molecular Diagnostics; 2. Monoclonal Antibodies; 3. Immunoassays; 4. Differential Light Scattering; 5. Information Technology; 6. Artificial Intelligence; 7. Liposomes; 8. Flow Cytometry; 9. Chromatography; 10. Diagnostic Imaging; 11. Gel Microdroplets; 12. Other
Japan: A. Executive Summary; B. Business Environment; C. Market Structure; D. Market Size, Growth and Major Suppliers
Major Product Development Opportunities: A. Instrumentation; B. Reagent Kits and Test Systems/Panels; C. Computers, Software and Automation; D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies: A. Internal Development; B. Collaborative Arrangements; C. University Contracts; D. Distribution Strategies for Decentralized
Potential Market Entry Barriers and Risks: A. Market Maturity; B. Cost Containment; C. Competition; D. Technological Edge and Limitations; E. Patent Protection; F. Regulatory Constraints; G. Decentralized Testing Market Challenges
Competitive Assessments: - Abbott; - Affymetrix; - Beckman Coulter/Danaher; - Becton Dickinson; - bioMerieux; - Bio-Rad; - Cepheid; - Diamedix; - DiaSorin; - Eiken Chemical; - Enzo Biochem; - Fujirebio; - Gen-Probe; - Hologic; - ID Biomedical; - Innogenetics/Solvay; - Kreatech; - Life Technology; - Lonza; - Nanogen/Elitech; - Novartis Diagnostics; - Ortho-Clinical Diagnostics; - Qiagen; - Roche; - Scienion; - Sequenom; - SeraCare; - Siemens; - Takara Bio; - Thermo Fisher; - Wallac; - Wako
List of Tables: Major Companies Developing or Marketing AIDS Tests; Major Companies Developing or Marketing Adenovirus Tests; Major Companies Developing or Marketing Bartonella Tests; Major Companies Developing or Marketing Campylobacter Tests; Major Companies Developing or Marketing Candida Tests; Major Companies Developing or Marketing Chlamydia Tests; Major Companies Developing or Marketing Clostridium Tests; Major Companies Developing or Marketing Coronavirus Tests; Major Companies Developing or Marketing Cryptosporidium Tests; Major Companies Developing or Marketing CMV Tests; Major Companies Developing or Marketing Echovirus Tests; Major Companies Developing or Marketing Enterovirus Tests; Major Companies Developing or Marketing EBV Tests; Major Companies Developing or Marketing Giardia Tests; Major Companies Developing or Marketing Gonorrhea Tests; Major Companies Developing or Marketing Hantavirus Tests; Major Companies Developing or Marketing Helicobacter Pylori Tests; Major Companies Developing or Marketing Hepatitis Tests; Major Companies Developing or Marketing Herpes Tests; Major Companies Developing or Marketing Influenza Tests; Major Companies Developing or Marketing Legionella Tests; Major Companies Developing or Marketing Lyme Disease Tests; Major Companies Developing or Marketing Lymphogranuloma Tests; Major Companies Developing or Marketing Malaria Tests; Major Companies Developing or Marketing Measles Tests; Major Companies Developing or Marketing Meningitis Tests; Major Companies Developing or Marketing Microsporidium Tests; Major Companies Developing or Marketing Mononucleosis Tests; Major Companies Developing or Marketing Mumps Tests; Major Companies Developing or Marketing Mycoplasma Tests; Major Companies Developing or Marketing Papilloma Virus Tests; Major Companies Developing or Marketing Parvovirus Tests; Major Companies Developing or Marketing Pneumonia Tests; Major Companies Developing or Marketing RSV Tests; Major Companies Developing or Marketing Rotavirus Tests; Major Companies Developing or Marketing Rubella Tests; Major Companies Developing or Marketing Salmonella Tests; Major Companies Developing or Marketing Septicemia Tests; Major Companies Developing or Marketing Shigella Tests; Major Companies Developing or Marketing Staphylococci Tests; Major Companies Developing or Marketing Streptococci Tests; Major Companies Developing or Marketing Syphilis Tests; Major Companies Developing or Marketing Toxoplasmosis Tests; Major Companies Developing or Marketing Trichomonas Tests; Major Companies Developing or Marketing Tuberculosis Tests; Major Companies Developing or Marketing West Nile Tests; Major Companies Developing or Marketing Yersinia Tests; Japan Summary Table All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Laboratories Performing Infectious Disease Tests by Market Segment; Japan Hospital Laboratories Performing Infectious Disease Tests by Bed Size; Japan Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume; Japan All Market Segments Infectious Disease Test Volume Forecast; Japan Hospital Laboratories Infectious Disease Test Volume Forecast; Japan Blood Banks Infectious Disease Test Volume Forecast; Japan Commercial/Private Laboratories Infectious Disease Test Volume Forecast; Japan All Market Segments Infectious Disease Diagnostics Market Forecast; Japan Hospital Laboratories Infectious Disease Diagnostics Market Forecast; Japan Blood Banks Infectious Disease Diagnostics Market Forecast; Japan Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast; Japan HIV or HIV I/HIV II Test Volume and Diagnostics Sales by Market Segment Forecast; Japan HIVAg Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment; Japan BEA Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Candida Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Coronavirus Test Volume and Diagnostics Sales Forecast by Market Segment; Japan CoxsackieVirus Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment; Japan CMV Test Volume and Diagnostics Sales Forecast by Market Segment; Japan E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment; Japan EBV Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Giardia Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment; Japan HantaVirus Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment; Japan HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment; Japan HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment; Japan HBsAg Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Anti-HBc Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Anti-HBs Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment; Japan HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment; Japan HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment; Japan ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment; Japan HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Influenza Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Legionella Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Malaria Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Measles Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Mumps Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Polyomaviruses Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Rabies Test Volume and Diagnostics Sales Forecast by Market Segment; Japan RSV Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Rubella Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Shigella Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment; Japan West Nile Test Volume and Diagnostics Sales Forecast by Market Segment; Japan Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment; Japan AIDS Testing Market Diagnostics Sales by Major Supplier; Japan Campylobacter Testing Market Diagnostics Sales by Major Supplier; Japan Candida Testing Market Diagnostics Sales by Major Supplier; Japan Chlamydia Testing Market Diagnostics Sales by Major Supplier; Japan CMV Testing Market Diagnostics Sales by Major Supplier; Japan Gonorrhea Testing Market Diagnostics Sales by Major Supplier; Japan Hepatitis Testing Market Diagnostics Sales by Major Supplier; Japan Hepatitis C Testing Market Diagnostics Sales by Major Supplier; Japan Herpes Testing Market Diagnostics Sales by Major Supplier; Japan Legionella Testing Market Diagnostics Sales Forecast by Major Supplier; Japan Meningitis Testing Market Diagnostics Sales by Major Supplier; Japan Mononucleosis Testing Market Diagnostics Sales by Major Supplier; Japan Mycoplasma Testing Market Diagnostics Sales by Major Supplier; Japan Pneumonia Testing Market Diagnostics Sales by Major Supplier; Japan RSV Testing Market Diagnostics Sales by Major Supplier; Japan Rotavirus Testing Market Diagnostics Sales by Major Supplier; Japan Rubella Testing Market Diagnostics Sales by Major Supplier; Japan Septicemia Testing Market Diagnostics Sales by Major Supplier; Japan Shigella Testing Market Diagnostics Sales by Major Supplier; Japan Streptococci Testing Market Diagnostics Sales by Major Supplier; Japan Syphilis Testing Market Diagnostics Sales by Major Supplier; Japan Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier; Japan Trichomonas Testing Market Diagnostics Sales by Major Supplier; Japan Tuberculosis Testing Market Diagnostics Sales by Major Supplier

Research assistance

We can help you find what you need. Call us or write us:

US: 800.298.5699

Int'l: +1.240.747.3093

Need help in your search?

Share this report

Email a colleague

Other tasks

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!